Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 37 Records) |
| Query Trace: Lung Neoplasms and Fgfr1[original query] |
|---|
| FGFR1 amplification is associated with poor prognosis and smoking in non-small-cell lung cancer. Virchows Archiv : an international journal of pathology 2014 Nov 465 (5): 547-58. Seo An Na, Jin Yan, Lee Hee Jin, Sun Ping-Li, Kim Hyojin, Jheon Sanghoon, Kim Kwhanmien, Lee Choon-Taek, Chung Jin-Hae |
| Prospective genetic profiling of squamous cell lung cancer and adenosquamous carcinoma in Japanese patients by multitarget assays. BMC cancer 2014 14 786. Kenmotsu Hirotsugu, Serizawa Masakuni, Koh Yasuhiro, Isaka Mitsuhiro, Takahashi Toshiaki, Taira Tetsuhiko, Ono Akira, Maniwa Tomohiro, Takahashi Shoji, Mori Keita, Endo Masahiro, Abe Masato, Hayashi Isamu, Nakajima Takashi, Ohde Yasuhisa, Yamamoto Nobuyu |
| [Advances on driver oncogenes of non-small cell lung cancer]. Zhongguo fei ai za zhi = Chinese journal of lung cancer 2015 1 18 (1): 42-7. Zhao Jianguo, Xiong Jianpi |
| FGFR gene alterations in lung squamous cell carcinoma are potential targets for the multikinase inhibitor nintedanib. Cancer science 2016 Sep . Hibi Masaaki, Kaneda Hiroyasu, Tanizaki Junko, Sakai Kazuko, Togashi Yosuke, Terashima Masato, De Velasco Marco Antonio, Fujita Yoshihiko, Banno Eri, Nakamura Yu, Takeda Masayuki, Ito Akihiko, Mitsudomi Tetsuya, Nakagawa Kazuhiko, Okamoto Isamu, Nishio Kazu |
| Genomic Profiling of Large-Cell Neuroendocrine Carcinoma of the Lung. Clinical cancer research : an official journal of the American Association for Cancer Research 2016 Aug . Miyoshi Tomohiro, Umemura Shigeki, Matsumura Yuki, Mimaki Sachiyo, Tada Satoshi, Ishii Genichiro, Udagawa Hibiki, Matsumoto Shingo, Yoh Kiyotaka, Niho Seiji, Ohmatsu Hironobu, Aokage Keiju, Hishida Tomoyuki, Yoshida Junji, Nagai Kanji, Goto Koichi, Tsuboi Masahiro, Tsuchihara Katsu |
| Programmed cell death-ligand 1 expression is associated with a favourable immune microenvironment and better overall survival in stage I pulmonary squamous cell carcinoma. European journal of cancer (Oxford, England : 1990) 2016 Feb 57 91-103. Yang Ching-Yao, Lin Mong-Wei, Chang Yih-Leong, Wu Chen-Tu, Yang Pan-Ch |
| Frequency of EGFR T790M mutation and multimutational profiles of rebiopsy samples from non-small cell lung cancer developing acquired resistance to EGFR tyrosine kinase inhibitors in Japanese patients. BMC cancer 2016 Nov 16 (1): 864. Ko Ryo, Kenmotsu Hirotsugu, Serizawa Masakuni, Koh Yasuhiro, Wakuda Kazushige, Ono Akira, Taira Tetsuhiko, Naito Tateaki, Murakami Haruyasu, Isaka Mitsuhiro, Endo Masahiro, Nakajima Takashi, Ohde Yasuhisa, Yamamoto Nobuyuki, Takahashi Kazuhisa, Takahashi Toshia |
| Clinical correlation of extensive-stage small-cell lung cancer genomics. Annals of oncology : official journal of the European Society for Medical Oncology 2016 Apr 27 (4): 642-7. Dowlati A, Lipka M B, McColl K, Dabir S, Behtaj M, Kresak A, Miron A, Yang M, Sharma N, Fu P, Wildey |
| Detection of Known and Novel FGFR Fusions in Non-Small Cell Lung Cancer by Comprehensive Genomic Profiling. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2018 9 14 (1): 54-62. Qin Angel, Johnson Adrienne, Ross Jeffrey S, Miller Vincent A, Ali Siraj M, Schrock Alexa B, Gadgeel Shirish |
| Concomitant driver mutations in advanced EGFR-mutated non-small-cell lung cancer and their impact on erlotinib treatment. Oncotarget 2018 May 9 (40): 26195-26208. Jakobsen Jan Nyrop, Santoni-Rugiu Eric, Grauslund Morten, Melchior Linea, Sørensen Jens Be |
| Genomic alterations of plasma cell-free DNAs in small cell lung cancer and their clinical relevance. Lung cancer (Amsterdam, Netherlands) 2018 Jun 120 113-121. Du Meijun, Thompson Jonathan, Fisher Hannah, Zhang Peng, Huang Chiang-Ching, Wang Lia |
| Preselection of Lung Cancer Cases Using FGFR1 mRNA and Gene Copy Number for Treatment With Ponatinib. Clinical lung cancer 2018 Sep . Ng Terry L, Yu Hui, Smith Derek E, Boyle Theresa A, York Emily R, Leedy Scott, Gao Dexiang, Aisner Dara L, Van Bokhoven Adrie, Heasley Lynn E, Hirsch Fred R, Camidge D Ro |
| Profiling the Mutational Landscape in Known Driver Genes and Novel Genes in African American Non-Small Cell Lung Cancer Patients. Clinical cancer research : an official journal of the American Association for Cancer Research 2019 4 25 (14): 4300-4308. Lusk Christine M, Watza Donovan, Dyson Greg, Craig Douglas, Ratliff Valerie, Wenzlaff Angela S, Lonardo Fulvio, Bollig-Fischer Aliccia, Bepler Gerold, Purrington Kristen, Gadgeel Shirish, Schwartz Ann |
| Impact of Somatic Mutations in Non-Small-Cell Lung Cancer: A Retrospective Study of a Chinese Cohort. Cancer management and research 2020 12 7427-7437. Shen Hai-Bo, Li Jie, Yao Yuan-Shan, Yang Zhen-Hua, Zhou Yin-Jie, Chen Wei, Hu Tian-J |
| mRNA Expression of FGFR1 as Potential Marker for Predicting Prognosis of Surgical Resection of Small Cell Lung Cancer may be better than Protein Expression and Gene Amplification. Journal of Cancer 2020 7 11 (16): 4691-4699. Qin Jing, Xie Fajun, Wang Fenfang, Lu Hongya |
| Genetic alterations in epidermal growth factor receptor-tyrosine kinase inhibitor-naïve non-small cell lung carcinoma. Oncology letters 2020 5 19 (6): 4169-4176. Yamaura Takumi, Muto Satoshi, Mine Hayato, Takagi Hironori, Watanabe Masayuki, Ozaki Yuki, Inoue Takuya, Fukuhara Mitsuro, Okabe Naoyuki, Matsumura Yuki, Hasegawa Takeo, Osugi Jun, Hoshino Mika, Higuchi Mitsunori, Shio Yutaka, Suzuki Hiroyu |
| Comprehensive Molecular Characterizations of Chinese Patients With Different Subtypes of Lung Squamous Cell Carcinoma. Frontiers in oncology 2020 10 607130. Qian Jie, Chen Rongrong, Zhao Ruiying, Han Yuchen, Yu Yongfe |
| Comprehensive genomic profile of Chinese lung cancer patients and mutation characteristics of individuals resistant to icotinib/gefitinib. Scientific reports 2020 Nov 10 (1): 20243. Shang Yanhong, Li Xiaofang, Liu Weiwei, Shi Xiaoliang, Yuan Shaohua, Huo Ran, Fang Guotao, Han Xiao, Zhang Jingnan, Wang Kunjie, Dou Zhengyue, Zhang Yan, Zang Aimin, Zhang L |
| A comprehensive pan-cancer study of fibroblast growth factor receptor aberrations in Chinese cancer patients. Annals of translational medicine 2020 11 8 (20): 1290. Sun Yi, Li Gao, Zhu Wei, He Qiuyan, Liu Yongchang, Chen Xianshan, Liu Juan, Lin Jing, Han-Zhang Han, Yang Zheng, Lizaso Analyn, Xiang Jianxing, Mao Xinru, Liu Hao, Gao Ya |
| Frequency of actionable molecular drivers in lung cancer patients with precocious brain metastases. Clinical neurology and neurosurgery 2021 Jul 208 106841. Hanke Benjamin, Jünger Stephanie T, Kirches Elmar, Waldt Natalie, Schreiber Jens, Lücke Eva, Franke Sabine, Sandalcioglu I Erol, Warnke Jan-Peter, Meisel Hans-Jörg, Prell Julian, Scheller Christian, Braunsdorf Werner E K, Preusser Matthias, Schildhaus Hans-Ulrich, Mawrin Christi |
| Detection of Genetic Mutations by Next-Generation Sequencing for Predicting Prognosis of Extensive-Stage Small-Cell Lung Cancer. Journal of oncology 2020 2020 8811487. Chen Dongfang, Xu Jianlin, Qiao Rong, Zhao Yizhuo, Chu Tianqing, Han Baohui, Zhong Run |
| Predictive values of genomic variation, tumor mutational burden, and PD-L1 expression in advanced lung squamous cell carcinoma treated with immunotherapy. Translational lung cancer research 2020 Dec 9 (6): 2367-2379. Xu Yanjun, Li Hui, Huang Zhiyu, Chen Kaiyan, Yu Xiaoqing, Sheng Jiamin, Zhang Han-Han, Fan Y |
| Genomic Profiling Reveals Novel Predictive Biomarkers for Chemo-Radiotherapy Toxicity and Efficacy in Non-Small-Cell Lung Cancer. International journal of radiation oncology, biology, physics 2021 Nov 111 (3S): e437. He K, Zhang S, Pang J, Yin J, Zhang J, Mu D, Tang S, Li L, Bao H, Wu X, Wang X, Shao Y, Yu J, Yuan |
| Efficacy and potential resistance mechanisms of afatinib in advanced non-small cell lung cancer patients with EGFR G719X/L861Q/S768I. Cancer 2022 Sep . Pang Lan-Lan, Gan Jia-Di, Tan Jia-Rong, Huang Yi-Hua, Liao Jun, Liang Wei-Ting, Deng Peng-Bo, Fang Wen-Fe |
| Genetic determinants of lung cancer: Understanding the oncogenic potential of somatic missense mutations. Genomics 2022 6 114 (4): 110401. Dhakar Ramgopal, Dakal Tikam Chand, Sharma Am |
| Genomic Alteration Spectrum of Non-Small Cell Lung Cancer Patients in East-China Characterized by Tumor Tissue DNA and Cell-Free DNA. OncoTargets and therapy 2022 5 15 571-584. Li Jie, Chen Siwen, Xue Hui, Wang Haoyi, Huang Tianwei, Xie Hongya, He Jiang, Ke Cai, Yu Zhaonan, Ni B |
| Lung cancer presenting with central nervous system metastasis: Clinicopathological and molecular analysis of 171 cases. Annals of diagnostic pathology 2023 1 63 152082. Demleitner Madeleine, Erlenbach-Wünsch Katharina, Coras Roland, Erber Ramona, Polifka Iris, Eyüpo?lu Ilker, Fuchs Florian, Hartmann Arndt, Agaimy Abb |
| A pilot study of nintedanib in molecularly selected patients with advanced non-small cell lung cancer. Journal of thoracic disease 2024 7 16 (6): 3782-3793. Christine Auberle, Feng Gao, Mark Sloan, Daniel Morgensztern, Linda Winkler, Jeffrey P Ward, Siddhartha Devarakonda, Timothy P Rearden, Ramaswamy Govindan, Saiama N Waq |
| Somatic KMT2D loss-of-function mutations in lung squamous cell carcinoma: a single-center cohort study. Journal of thoracic disease 2024 6 16 (5): 3338-3349. Zekui Fang, Xiping Wu, Li Xiao, Chunli Wang, Yanyan Zhao, Qingchao Zhang, Paola Anna Jablonska, Alonso La Rosa, Wolfram C M Dempke, Muhammad Furqan, Huizhen F |
| Evaluation of molecular residual disease in operable non-small cell lung cancer with gene fusions, MET exon skipping or de novo MET amplification. Frontiers of medicine 2024 5 . Rui Fu, Yuanyuan Xiong, Miao Cai, Fang Li, Rongrong Chen, Yilong Wu, Wenzhao Zho |
- Page last reviewed:Feb 1, 2024
- Content source: